Shares of aesthetic and dermatology solutions provider Cutera (NASDAQ:CUTR) have skyrocketed today on the back of its third-quarter showing.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Revenue rose 9.4% year-over-year to $62.8 million, in line with estimates. Net loss per share at $0.62 though, came in wider than estimates by $0.24.
Nonetheless, the company is seeing capital equipment and consumable product demand and witnessed more than 100 new placements of AviClear devices during the quarter.
Looking ahead, for 2022, Cutera now expects to end the year at the upper end of its top-line guidance of $255 million and $260 million. In constant currency terms, this indicates a growth between 18% and 20%.
Further, the company anticipates placing 200 more AviClear devices in the fourth quarter, taking the total tally to about 350.
Read full Disclosure